Skip to main content
EN

Enveda

Boulder, United States
Last funding
$311.0M
Series ESep 2026

Enveda discovers medicines by studying the chemistry of nature and translating natural compounds into potential therapeutic candidates.

About Enveda

How much funding has Enveda raised?

Enveda has raised $311.0M in total funding. The most recent round was Series E. The last funding was announced in September 2026.

Who are Enveda's investors?

Enveda's investors include Lightspeed Venture Partners, Catalio Capital Management, Lux Capital, FPV Ventures, T. Rowe Price.

Where is Enveda headquartered?

Enveda is headquartered in Boulder, United States.

What does Enveda do?

Enveda discovers medicines by studying the chemistry of nature and translating natural compounds into potential therapeutic candidates.

What stage is Enveda at?

Enveda is at the Series E stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Enveda — Funding & Investors." VCBacked, September 23, 2026, https://www.vcbacked.co/company/enveda. Accessed November 16, 2026.
APA
VCBacked. (2026). Enveda — Funding & Investors. Retrieved November 16, 2026, from https://www.vcbacked.co/company/enveda
Wikipedia (cite web)
{{cite web |title=Enveda — Funding & Investors |url=https://www.vcbacked.co/company/enveda |website=VCBacked |access-date=November 16, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Enveda? Request a listing update

Founder contacts
m***@enveda.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →